Informazione:
Errore:
ID
22157
Descrizione
Parcopa Versus Carbidopa-Levodopa in a Single Dose Cross-Over Comparison Study; ODM derived from: https://clinicaltrials.gov/show/NCT00590122
collegamento
https://clinicaltrials.gov/show/NCT00590122
Keywords
versioni (1)
- 21/05/17 21/05/17 -
Caricato su
21 maggio 2017
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY 4.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
Eligibility Parkinson's Disease NCT00590122
Eligibility Parkinson's Disease NCT00590122
- StudyEvent: Eligibility
Similar models
Eligibility Parkinson's Disease NCT00590122
- StudyEvent: Eligibility
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
gender, age, parkinson
Item
male or female between the age of 31 and 80 -diagnosis of idiopathic parkinson's disease for at least three years duration
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0030567 (UMLS CUI [3])
C0001779 (UMLS CUI [2])
C0030567 (UMLS CUI [3])
levodopa
Item
patients requiring levodopa for their pd
boolean
C0023570 (UMLS CUI [1])
levodopa response
Item
good subjective response to levodopa
boolean
C0023570 (UMLS CUI [1,1])
C1704632 (UMLS CUI [1,2])
C1704632 (UMLS CUI [1,2])
parkinson symptoms
Item
fluctuating symptoms defined by wearing off phenomenon, any dyskinesia, and/or dose failures
boolean
C0030567 (UMLS CUI [1,1])
C1457887 (UMLS CUI [1,2])
C1457887 (UMLS CUI [1,2])
updrs
Item
a updrs -off- motor score of at least 25
boolean
C3639721 (UMLS CUI [1])
informed consent
Item
subjects willing to give informed consent
boolean
C0021430 (UMLS CUI [1])
compliance
Item
subjects who are able and willing to comply with study procedures
boolean
C1321605 (UMLS CUI [1])
birth control
Item
if female of child-bearing potential, will use one of the approved birth control measures:
boolean
C0700589 (UMLS CUI [1])
hormonal contraceptives
Item
1. hormonal contraceptives
boolean
C0009907 (UMLS CUI [1])
spermicidal, barrier
Item
2. spermicidal and barrier
boolean
C0037862 (UMLS CUI [1])
C0004764 (UMLS CUI [2])
C0004764 (UMLS CUI [2])
intrauterine device
Item
3. intrauterine device
boolean
C0021900 (UMLS CUI [1])
partner infertility
Item
4. partner sterility
boolean
C0021359 (UMLS CUI [1,1])
C0682323 (UMLS CUI [1,2])
C0682323 (UMLS CUI [1,2])
dementia
Item
subjects with evidence of significant dementia
boolean
C0497327 (UMLS CUI [1])
oral lesions
Item
subjects with significant oral lesions
boolean
C0026636 (UMLS CUI [1])
cardiac disease
Item
history of unstable cardiac disease including angina or congestive heart failure within 3 months prior to study entry
boolean
C0018799 (UMLS CUI [1])
renal disease
Item
history of clinically significant renal disease including renal insufficiency of sufficient degree to require adjunctive treatment or dietary restrictions
boolean
C0022658 (UMLS CUI [1])
hepatic disease
Item
history of clinically significant hepatic disease, including previously documented cirrhosis or hepatic insufficiency or jaundice within 3 months prior to study entry.
boolean
C0023895 (UMLS CUI [1])
levodopa response
Item
subjects with poor response to levodopa
boolean
C0023570 (UMLS CUI [1,1])
C1704632 (UMLS CUI [1,2])
C1704632 (UMLS CUI [1,2])
pregnancy, breast feeding
Item
women who are pregnant, breast-feeding, or planning to become pregnant during this study are excluded from participation due to unknown effects of the study drug on the fetus.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])